$3.8bn
$XXX.Xm
4,947
378
$XXX.Xm
The proliferation of low-cost generic oral hair loss treatments in recent years has made such treatments more accessible. However, the prevalence of generic products has intensified competitive price pressures, adversely affecting industry revenue. Furthermore, demand for hair loss treatments declined in 2020 because of COVID-19. Also, consumer confidence has dropped for most of the period and soaring inflation has caused interest rates to skyrocket. So, industry-wide revenue has been decreasing at a CAGR of 2.0% over the past five years, including an estimated 3.3% increase in the current year, and is expected to total $3.8 billion in 2023. In the same year, profit is projected to plateau to 9.6%.Hair loss affects both men and women, with some forms of hair loss, like involutional alopecia, becoming more prevalent with age. According to the American Hair Loss Association, about 85.0% of men will experience thinning hair by the age of 50. Meanwhile, women comprise an estimated 40.0% of individuals contending with hair loss in the United States. Hair loss can be attributed to several factors, including genetics, illness and medication side effects. According to the International Society of Hair Restoration Surgery, more than 75% of individuals surveyed who received hair-loss treatment in 2022 sought treatment because of genetic hair loss (latest data available). Other reasons cited included reconstructive needs at 4.0%, post-cosmetic surgery needs at 3.0%, transgender needs at 1.6% and other reasons, like diseases, at 9.4%. Following hair transplants, some patients require additional treatment, like minoxidil, copper peptide solutions, low-level laser therapies and platelet-rich plasma.The hair loss treatment industry likely benefits from increased demand by individuals experiencing hair loss as a direct side effect of using various medications like blood thinners, cholesterol-lowering or beta-blocking drugs. Furthermore, large wholesalers and supermarkets seeking to produce their own store-brand products may create additional demand for hair loss treatments, boosting competition in the industry. So, industry revenue is expected to increase at a CAGR of 2.1% over the next five years, reaching $4.2 billion in 2028. Still, strong demand for products manufactured overseas and low-cost generic oral hair loss treatments will continue to stifle growth.
Industry revenue has declined at a CAGR of 2.0 % over the past five years, to reach an estimated $3.8bn in 2023.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2023 | Revenue ($m)
2023 | Profit ($m)
2023 | Profit Margin (%)
2023 |
---|---|---|---|---|
Johnson & Johnson | 44.8 | 6.9 | 15.4 |
To view the market share and analysis for all 1 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Topical treatments, Shampoo and Laser treatments. Topical treatments is the largest segment of the Hair Loss Treatment Manufacturing in the US.
Oral and topical hair loss treatments account for the majority of revenue
This industry develops and produces solutions that prevent or restore hair loss. Products in this industry include topical applications, orally ingestible treatments, hair transplants and laser follicle stimulation.
Purchase this report to view all 1 major companies in this industry.
NAICS 32562 - Hair Loss Treatment Manufacturing in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
The Hair Loss Treatment Manufacturing industry has faced challenges. COVID-19 and the increased market presence of generic substitutes have impacted the industry's expansion.
Learn about an industry's products and services, markets and trends in international trade.
The hair loss treatment industry is dominated by oral and topical products like Propecia, Rogaine, and biotin. Most are easily accessible without a prescription, except for f...
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
The Hair Loss Treatment Manufacturing industry is highly concentrated in the West and Mid-Atlantic regions of the United States. The Mid-Atlantic region is home to large phar...
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Product diversity is the driving factor of competition among hair loss treatment manufacturers. To appeal to all consumer segments, they must create and market various produc...
Learn about the performance of the top companies in the industry.
The Hair Loss Treatment Manufacturing industry has no easily distinguishable top player; this is particularly because several manufacturers have lost their patents, which has ...
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
The FDA tightly regulates the Hair Loss Treatment Manufacturing industry, requiring extensive data to show product safety and efficacy. Marked products face ongoing review, w...
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Patent expirations for key hair loss treatments have reduced profit growth. Also, forced closures during COVID-19 greatly impacted the industry demand.
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Hair Loss Treatment Manufacturing in the US industry in United States is $3.8bn in 2024.
There are 378 businesses in the Hair Loss Treatment Manufacturing in the US industry in United States, which has grown at a CAGR of 3.3 % between 2018 and 2023.
The market size of the Hair Loss Treatment Manufacturing in the US industry in United States has been declining at a CAGR of 2.0 % between 2018 and 2023.
Over the next five years, the Hair Loss Treatment Manufacturing in the US industry in United States is expected to grow.
The biggest company operating in the Hair Loss Treatment Manufacturing market in United States is Johnson & Johnson
Developing and manufacturing orally ingested hair loss treatments and Developing and manufacturing hair loss treatments for topical application are part of the Hair Loss Treatment Manufacturing in the US industry.
The company holding the most market share in United States is Johnson & Johnson.
The level of competition is moderate and increasing in the Hair Loss Treatment Manufacturing in the US industry in United States.